2023 India Healthcare and Lifesciences Investment Outlook

2023 India Healthcare and Lifesciences Investment Outlook

Since 2013 our algos have been accurately predicting the investment heatmap in the healthcare and life sciences in India which were predicting with 95% accuracy on the sectoral investment cycle in India till the end of 2019. Since the Covid Pandemic in 2020 we lowered levels of prediction accuracy like we started back in 2013.… Continue reading 2023 India Healthcare and Lifesciences Investment Outlook

Budget 2022: When is Healthcare’s Amrit Kaal Coming?

Budget 2022: When is Healthcare’s Amrit Kaal Coming?

Preamble On 1 February 2022, our Hon. Finance Minister presented her fourth budget in the Parliament and introduced the “Amrit Kaal” in Point 4 of her speech, “we are marking Azadi ka Amrit Mahotsav, and have entered into Amrit Kaal, the 25-year-long leadup to India@100. Hon’ble Prime Minister in his Independence Day address had set-out… Continue reading Budget 2022: When is Healthcare’s Amrit Kaal Coming?

2022: Healthcare and Life Sciences Investment Outlook

2022: Healthcare and Life Sciences Investment Outlook

Since 2013 our algos have been accurately predicting the investment heatmap in the healthcare and life sciences in India which were predicting with 95% accuracy on the sectoral investment cycle in India till the end of 2019. Since the Covid Pandemic in 2020 we lowered levels of prediction accuracy like we started back in 2013.… Continue reading 2022: Healthcare and Life Sciences Investment Outlook

Why India is not selling its Healthcare Assets Under National Monetisation Pipeline (NMP) 2021?

Healthcare Assets Under National Monetisation Pipeline (NMP) 2021

Preamble On 23 August 2021 the government announced a National Monetisation Pipeline of INR 6 tn, (~2.6% of GDP), aimed at monetising its brownfield infrastructure to fund greenfield ones. Most of these projects will be concentrated in the roads, railways, and power sectors and no monetisation of India’s healthcare assets. NMP provides the guide to… Continue reading Why India is not selling its Healthcare Assets Under National Monetisation Pipeline (NMP) 2021?

Our Recommendations on the Working Group Report on Inclusive Regulatory Framework for Social Stock Exchange (SSE) in India

Cover Letter to SEBI Social Stock Exchange Working Group Shri Ishaat Hussain Chairman, SEBI Social Stock Exchange Working Group Plot No. C 4-A , G Block, SEBI Bhavan, Bandra Kurla Complex, Bandra East, Mumbai – 400051 Dear Sir, Re: Our Recommendations on the Working Group Report on Social Stock Exchange (SSE) At the outset we… Continue reading Our Recommendations on the Working Group Report on Inclusive Regulatory Framework for Social Stock Exchange (SSE) in India